- Home
- BNTX vs ARE Comparison
BNTX vs ARE Comparison
Compare BNTX & ARE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BNTX | ARE |
|---|---|---|
| Founded | 2008 | 1994 |
| Country | Germany | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 24.8B | 8.8B |
| IPO Year | 2019 | 1997 |
Fundamental Metrics
Financial Performance| Metric | BNTX | ARE |
|---|---|---|
| Price | $92.40 | $48.22 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 11 | 10 |
| Target Price | ★ $137.40 | $62.75 |
| AVG Volume (30 Days) | 1.5M | ★ 3.4M |
| Earning Date | 11-03-2025 | 01-26-2026 |
| Dividend Yield | N/A | ★ 9.76% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $3,698,814,972.00 | $3,058,395,000.00 |
| Revenue This Year | $2.36 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 3.70 | N/A |
| 52 Week Low | $81.20 | $44.10 |
| 52 Week High | $129.27 | $105.14 |
Technical Indicators
Market Signals| Indicator | BNTX | ARE |
|---|---|---|
| Relative Strength Index (RSI) | 35.58 | 41.07 |
| Support Level | $91.11 | $45.73 |
| Resistance Level | $93.76 | $49.17 |
| Average True Range (ATR) | 2.08 | 1.75 |
| MACD | -0.33 | 0.79 |
| Stochastic Oscillator | 15.27 | 40.90 |
Price Performance
Historical ComparisonAbout BNTX BioNTech SE
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and antibody-drug conjugates, or ADCs. Comirnaty, its Pfizer-partnered covid vaccine, is its first commercialized product.
About ARE Alexandria Real Estate Equities Inc.
Alexandria Real Estate Equities Inc is an urban office real estate investment trust (REIT). It is engaged in the business of providing space for lease to life science, agtech, and technology tenants. The company has established a market presence in key locations, including Greater Boston, the San Francisco Bay Area, New York City, San Diego, Seattle, Maryland, and Research Triangle, Texas, and Canada. The Company is a life science real estate investment trust focused on developing, redeveloping, and operating properties that provide space for lease to tenants in the life science industry.